Skip to content

Clinical Research on the Accurate Diagnosis and Optimal Management of Early Stage and Metastatic Lung Cancer

Clinical Research on the Accurate Diagnosis and Optimal Management of Early Stage and Metastatic Lung Cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DDD-16009394
Enrollment
Unknown
Registered
2016-10-22
Start date
2017-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer

Interventions

Gold Standard:
Index test:

Sponsors

Shanghai 10th People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Male or female aged 18 to 70 years; 2. consistent with the diagnosis of asymptomatic pulmonary nodules (nodular diameter=3 cm); 3. voluntary participate the clinical research and sign on the informed consent.

Exclusion criteria

Exclusion criteria: 1. patients with other primary malignancies within 5 years; 2. Patients with serious diseases and severe dysfunction of the heart, liver, kidney; 3. Patients who are undergoing adjuvant chemotherapy, or underwent chemotherapy in the past; 4. pregnant or lactating women; 5. Patients with mental or cognitive impairment which influence the quality of life in this study; 6. Patients who are participating in other clinical trials; 7. Patients with poor compliance or other situations the researchers believe that is not eligible for inclusion.

Design outcomes

Primary

MeasureTime frame
Detection value;

Countries

China

Contacts

Public ContactFan Lihong

Shanghai 10th People's Hospital

fanlih@qliyun.com+86 13661599588

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026